Dr. Michael D. Ingegno, MD

Dr. Ingegno practices at Novelty Surgical Center in San Leandro, California.

Dr. Ingegno's NPI, 1447270459, was assigned on July 20, 2006. Dr. Ingegno graduated from SUNY Downstate Health Sciences University in 1988. Dr. Ingegno holds California license G68202.

Dr. Ingegno's primary practice is Novelty Surgical Center, at 13851 E 14th St, San Leandro, CA 94578 in Alameda County. The practice phone is (661) 288-5700.

Dr. Ingegno's primary practice is Novelty Surgical Center in San Leandro, California. Dr. Ingegno is also affiliated with Alta Bates Summit Medical Center. The medical group on file is Vascular Surgery Medical Group. Dmand AI also links Dr. Ingegno to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ingegno practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Ingegno's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Ingegno is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Ingegno's licenses on file in 2 states: California and Florida.

Dmand AI lists blood vessel access for dialysis, chronic skin ulcer, deep vein thrombosis (DVT), leg revascularization, peripheral vascular disease, varicose veins and varicose vein treatment among the conditions Dr. Ingegno treats.

CMS data shows 1,729 Medicare services from Dr. Ingegno across 26 procedure codes in 2024, for 774 Medicare patients. Medicare paid $257,252 for them.

CMS counts 774 Medicare patients who saw Dr. Ingegno in 2024. The largest group is 65 to 74, with 279 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 54% are also on Medicaid. Their average risk score is 3.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ingegno's median patient age at 64, with 52% women.

In 2024, Dr. Ingegno wrote 278 Medicare Part D claims for 97 patients. 74% of them were for generic drugs. CMS names the drug for 217 of them, across 8 drugs with 11 or more claims each, at $69,964 in total drug cost. In 2023, CMS named 122 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Ingegno for performance year 2024, reported individually. Dr. Ingegno accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ingegno as offering telehealth. CMS counts 19 procedures of leg revascularization (restoring blood flow) by Dr. Ingegno, more than 79% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Ingegno. The most frequent topics are Arterial Occlusive Diseases, Length of Stay and Postoperative Complications. Dr. Ingegno has published most often in J Vasc Surg. Dr. Ingegno's most frequent co-authors are Gail T. Tominaga, MD, Kenneth Waxman, MD and Elias J. Arous, MD.

CMS Open Payments shows 233 general payments to Dr. Ingegno from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 53% of the total. Cardinal Health Inc paid the most, $5,013.

Dmand AI lists 2 awards for Dr. Ingegno, most recently CMS Stage 1 EHR in 2013.

Dr. Ingegno graduated from SUNY Downstate Health Sciences University in 1988. Dr. Ingegno is a member of ACS and SVS.

Dr. Ingegno is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.